Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Institut Pasteur de Montevideo and Universidad de la Republica describe new trolox derivatives

March 21, 2018

Lycera patents new Rho-associated protein kinase 1/2 inhibitors

March 19, 2018

New polynucleotides encoding semaphorin-6 synthesized at Kanazawa University

March 8, 2018

Novel NF-kappaB inhibitors synthesized at University College Dublin

March 8, 2018

CYP11A1 expression identifies anaphylaxis risk in children with peanut allergy

March 5, 2018

Bristol-Myers Squibb presents phase Ib data for anti-PD-L1 BMS-936559 in sepsis

March 1, 2018

Accro Bioscience divulges necrosis inhibitors

Feb. 16, 2018

Galecto Biotech discovers galectin inhibitors

Feb. 1, 2018

Blade Therapeutics identifies new calpain inhibitors

Jan. 29, 2018

BI-2545 shows promise for the unmet medical need in IPF treatment

Jan. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 11, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...